Managing Diabetic Dyslipidemia: Aggressive Approach

被引:0
|
作者
Spratt, Kelly Anne [1 ]
机构
[1] Univ Penn, Sch Med, Med, Philadelphia, PA 19104 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The United States is experiencing a marked increase in rates of diabetes mellitus and metabolic syndrome, almost certainly in part due to the increase in obesity rates. This phenomenon is likely to also result in an increased risk of coronary artery disease as risk factors increase exponentially. This article defines diabetic dyslipidemia, the rationale for aggressive treatment, and options for ongoing management, including nonpharmacologic therapy and medications, alone or in combination, for management of all aspects of the lipid profile.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [31] Managing diabetes after myocardial infarction - Time for a more aggressive approach
    Nattrass, M
    BRITISH MEDICAL JOURNAL, 1997, 314 (7093): : 1497 - 1497
  • [32] Managing dyslipidemia in chronic kidney disease
    Harper, Charles R.
    Jacobson, Terry A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (25) : 2375 - 2384
  • [33] Managing dyslipidemia in chronic kidney disease
    Weiner, DE
    Sarnak, MJ
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (10) : 1045 - 1052
  • [34] Managing Outpatients with Dyslipidemia in a University Hospital
    Choi, Ha Jung
    Lee, Kayoung
    Kim, Bit Na
    Park, Tae Jin
    Lee, Jeong Nyeo
    KOREAN JOURNAL OF FAMILY MEDICINE, 2005, 26 (07): : 384 - 390
  • [35] Novel Therapeutic Targets for Managing Dyslipidemia
    Sathiyakumar, Vasanth
    Kapoor, Karan
    Jones, Steven R.
    Banach, Maciej
    Martin, Seth S.
    Toth, Peter P.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (08) : 733 - 747
  • [36] Managing Dyslipidemia in Type 2 Diabetes
    Nelson, Adam J.
    Rochelau, Simon K.
    Nicholls, Stephen J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 153 - +
  • [37] Managing dyslipidemia in chronic kidney disease
    Daniel E. Weiner
    Mark J. Sarnak
    Journal of General Internal Medicine, 2004, 19 : 1045 - 1052
  • [38] Atherogenic dyslipidemia and diabetic nephropathy
    Giuseppina Russo
    Pamela Piscitelli
    Annalisa Giandalia
    Francesca Viazzi
    Roberto Pontremoli
    Paola Fioretto
    Salvatore De Cosmo
    Journal of Nephrology, 2020, 33 : 1001 - 1008
  • [39] Diabetic dyslipidemia and its therapy
    Garg, A
    Grundy, SM
    DIABETES REVIEWS, 1997, 5 (04): : 425 - 433
  • [40] Diabetic dyslipidemia: evaluation and mechanism
    Yanai, Hidekatsu
    Hirowatari, Yuji
    Yoshida, Hiroshi
    GLOBAL HEALTH & MEDICINE, 2019, 1 (01): : 30 - 35